Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillation

2009/09/13 by Jason Pellman, Robert C. Lyon, Farah Sheikh · 26 citations
Medicine · #Atrial Fibrillation Management and Outcomes #Cardiac Arrhythmias and Treatments #Cardiac Fibrosis and Remodeling

paper · doi:10.1016/j.yjmcc.2009.09.001

Cited by

• Identification of atrial myopathy and atrial fibrillation recurrence after ablation using 3D left atrial phasic strain from retrospective gated computed tomography
• Understanding the role of the extracellular matrix in cardiovascular development and disease: where do we go from here? [europepmc]
• Drosophila as a model to study cardiac aging. [europepmc]
• Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. [europepmc]
• A dual role for integrin-linked kinase and β1-integrin in modulating cardiac aging. [europepmc]
• Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. [europepmc]
• Atrial remodeling, fibrosis, and atrial fibrillation. [europepmc]
• Autophagy is a regulator of TGF-β1-induced fibrogenesis in primary human atrial myofibroblasts. [europepmc]
• Crosstalk of cardiomyocytes and fibroblasts in co-cultures. [europepmc]
• Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling. [europepmc]
• A Computer Simulation Study of Anatomy Induced Drift of Spiral Waves in the Human Atrium. [europepmc]
• Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. [europepmc]
• Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems. [europepmc]
• Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate. [europepmc]
• Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1. [europepmc]
• Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. [europepmc]
• Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications. [europepmc]
• Phrase mining of textual data to analyze extracellular matrix protein patterns across cardiovascular disease. [europepmc]
• Doxycycline Attenuates Atrial Remodeling by Interfering with MicroRNA-21 and Downstream Phosphatase and Tensin Homolog (PTEN)/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway. [europepmc]
• Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II-Induced Differentiation of Human Atrial Fibroblasts into Myofibroblasts. [europepmc]
• Genetics and Epigenetics of Atrial Fibrillation. [europepmc]
• ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway. [europepmc]
• Angiotensin II-Treated Cardiac Myocytes Regulate M1 Macrophage Polarization via Transferring Exosomal PVT1. [europepmc]
• MicroRNA-146b-5p promotes atrial fibrosis in atrial fibrillation by repressing TIMP4. [europepmc]
• The Pathogenesis of Cardiac Arrhythmias in Vitamin D Deficiency. [europepmc]
• Biomimetic design of bioartificial scaffolds for the in vitro modelling of human cardiac fibrosis. [europepmc]